OVID·690469101·US·equity·Healthcare - Biotechnology-13D/G
OVID (Ovid Therapeutics Inc.) is held by 50 institutional investors as of Q4 2025. Largest holders: RA CAPITAL MANAGEMENT, L.P. ($17.5M), Point72 Asset Management, L.P. ($5.8M), ADAGE CAPITAL PARTNERS GP, L.L.C. ($5.7M). Net institutional sentiment: Mixed.
See how OVID's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer